The Eczema Area and Severity Index: An important update on validity and reliability.

The article discusses the importance of the Eczema Area and Severity Index (EASI) in assessing signs of atopic dermatitis (AD) in clinical trials and clinical practice. The study by Jacobson et al. evaluates the validity and reliability of EASI across different populations, highlighting its importance in interpreting outcomes for individuals with AD. The research addresses validation gaps and remaining questions, emphasizing the need for well-designed studies to measure outcomes accurately in both children and adults with AD. [Extracted from the article]